vimarsana.com
Home
Live Updates
GLP-1 Agonists can reduce risk of mortality, liver failure i
GLP-1 Agonists can reduce risk of mortality, liver failure i
GLP-1 Agonists can reduce risk of mortality, liver failure in patients with type 2 diabetes and cirrhosis
Taiwan: A recent population-based cohort study published in Clinical Gastroenterology and Hepatology has revealed multiple benefits of glucagon-like peptide-1 receptor agonist (GLP-1 RA) in patients...
Related Keywords
Taiwan ,
Taipei ,
T Ai Pei ,
Chiao Tung University ,
Xinzhu Xian ,
Cheng Chung Wei ,
Clin Gastroenterol Hepatol ,
National Yang Ming Chiao Tung University ,
National Health Insurance Research Database Of Taiwan ,
Chii Min Hwu ,
National Health Insurance Research Database ,
Agonist Use ,
Patients With Liver Cirrhosis ,
Clin Gastroenterol ,
Clinical Gastroenterology And Hepatology ,
Cardiovascular Events ,
Type 2 Diabetes ,
Cirrhosis ,
Liver Failure ,
Ortality ,
Hepatic Encephalopathy ,
Lucagon Like Peptide1 Receptor Agonist ,
Liver ,
Decompensated Cirrhosis ,